| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.47 | 0.006 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.009 |